Julie Andrews

This profile gathers the share dealings of Julie Andrews across 3 companies, led by Wright Medical Group N.V., RxSight, Inc. and Orthofix Medical Inc. Over a trading history stretching from 2 June 2016 to 17 June 2026, the count stands at 39 filings.

Both buying and selling appear: 1 purchase worth €211k, against 16 sales worth €1.5M. Netting one side against the other leaves €1.3M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 17 share grants and 1 option exercise. In 2026 alone, the filings show no purchases and 3 sales.

The record was last updated on 18 June 2026 with a share grant in RxSight, Inc. The last purchase on record was published on 5 August 2021, which is 1,905 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.